Report Categories
View AllRecent Articles
View All
STZ Constellation Brands posts 95 percent Q1 2026 EPS beat but shares fall 24 percent today
What Oxbridge OXBR does that makes it resilient 256 20260506
SANM Sanmina Corporation beats EPS estimates by 292 percent in Q1 2026 stock rises 25 percent
ROL Rollins posts tiny Q1 2026 EPS beat shares dip 074 percent amid lukewarm investor sentiment
TrumpBacked Challenger Unseats Incumbent Senator Political Risk Weighs on Market Sentiment
HMRC Selects UK AI Firm Quantexa for 175m Tax Fraud Detection Contract
Vishay Intertechnology VSH Falls 167 Watching 3548 Support 20260515
UK Gilts Steady as Prospective PM Andy Burnham Seeks to Reassure Bond Markets
General Motors Introduces AllElectric Cadillac Vistiq with Over 300Mile Range
Federal Reserve Faces Dwindling Case for Interest Rate Cuts as Jobs Data Highlights Persistent CostofLiving Concerns
At Least 90 Killed in Chinese Coal Mine Explosion Worst Disaster in 17 Years
Nicki Minajs Praise of Elon Musk at SpaceX Starbase Event Highlights Celebrity Endorsement Amid Starship V3 Delay
Genpact CEO Warns AI Will Reduce IT Workload and Jobs Demands Higher Skill Sets
Expert View Buy on Dips Strategy May Be Avoided Amid Market Volatility Says HDFC Securities Analyst
MX Q1 2026 Earnings EPS Beat by 5146 but Stock Declines 67
Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage
AVNT Q1 2026 Earnings Slight EPS Beat Fails to Inspire Market
NMI Holdings Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly
ULCC Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline
LFST Q1 2026 Earnings Significant EPS Beat Fails to Lift Shares
Syntec Optics Holdings OPTX Slides 575 as Selling Pressure Intensifies
Green Brick Partners Holds Near Support Amid Modest Decline
eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074
Rekor Systems REKR Rebounds 421 as Shares Test Key Resistance
Alnylam Pharmaceuticals ALNY Holds Steady Near Support Amid Biotech Sector Volatility